MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable and tailored medicines.
Location: Netherlands, South Holland, Oegstgeest
Employees: 51-200
Phone: +31 85 888 3161
Total raised: $25.2M
Founded date: 2013
Investors 5
Date | Name | Website |
- | Merieux De... | merieux-pa... |
- | Zeeuws Inv... | zeeuwsinve... |
- | BioHealth ... | biohealthi... |
- | Aglaia Onc... | aglaia-onc... |
- | Korys | korys.be |
Funding Rounds 2
Date | Series | Amount | Investors |
11.04.2018 | Series B | $20M | - |
08.10.2014 | - | $5.2M | - |
Mentions in press and media 3
Date | Title | Description | Source |
17.12.2021 | Inventia Life Science raises $25M, launches ‘RASTRUM’ 3D bio... | Australian 3D bioprinting specialist Inventia Life Science has announced the closure of a Series B f... | 3dprinting... |
11.04.2018 | Mimetas Secures $20M in Series B Financing | Mimetas, a Leiden, the Netherlands, and Gaithersburg, USA-based developer of organ-on-a-chip product... | finsmes.co... |
08.10.2014 | Mimetas Raises $5.2M in Funding | Mimetas B.V., a Leiden, The Netherlands-based developer of organ-on-a-chip technology, raised $5.2m ... | finsmes.co... |